LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 108 of 166
Next
>>
>
2676 to 2700 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	GSK1059615	0.37	uM	LJP6	72	hr	1097	1796	3673	0.4894	0.3268
BT-20	GSK1059615	1.11	uM	LJP5	72	hr	1097	596	3846	0.1549	-0.2873
BT-20	GSK1059615	1.11	uM	LJP6	72	hr	1097	775	3673	0.2114	-0.1810
BT-20	GSK1059615	3.33	uM	LJP5	72	hr	1097	474	3846	0.1230	-0.3734
BT-20	GSK1059615	3.33	uM	LJP6	72	hr	1097	514	3673	0.1399	-0.3533
BT-20	GSK1059615	10	uM	LJP5	72	hr	1097	354	3846	0.0918	-0.4691
BT-20	GSK1059615	10	uM	LJP6	72	hr	1097	454	3673	0.1240	-0.3978
BT-20	Brivanib	0.04	uM	LJP5	72	hr	1097	3576	3846	0.9300	0.9214
BT-20	Brivanib	0.12	uM	LJP5	72	hr	1097	3567	3846	0.9269	0.9168
BT-20	Brivanib	0.37	uM	LJP5	72	hr	1097	3699	3846	0.9621	0.9572
BT-20	Brivanib	1.11	uM	LJP5	72	hr	1097	3575	3846	0.9294	0.9202
BT-20	Brivanib	3.33	uM	LJP5	72	hr	1097	3666	3846	0.9541	0.9485
BT-20	Brivanib	10	uM	LJP5	72	hr	1097	3290	3846	0.8547	0.8326
BT-20	CHIR-99021	0.04	uM	LJP6	72	hr	1097	3192	3673	0.8686	0.8439
BT-20	CHIR-99021	0.12	uM	LJP6	72	hr	1097	3254	3673	0.8862	0.8656
BT-20	CHIR-99021	0.37	uM	LJP6	72	hr	1097	3245	3673	0.8833	0.8619
BT-20	CHIR-99021	1.11	uM	LJP6	72	hr	1097	3370	3673	0.9176	0.9036
BT-20	CHIR-99021	3.33	uM	LJP6	72	hr	1097	3450	3673	0.9386	0.9267
BT-20	CHIR-99021	10	uM	LJP6	72	hr	1097	2811	3673	0.7649	0.7140
BT-20	Linifanib	0.04	uM	LJP6	72	hr	1097	3950	3673	1.0759	1.0857
BT-20	Linifanib	0.12	uM	LJP6	72	hr	1097	3763	3673	1.0247	1.0279
BT-20	Linifanib	0.37	uM	LJP6	72	hr	1097	3801	3673	1.0348	1.0397
BT-20	Linifanib	1.11	uM	LJP6	72	hr	1097	3843	3673	1.0465	1.0530
BT-20	Linifanib	3.33	uM	LJP6	72	hr	1097	3739	3673	1.0179	1.0204
BT-20	Linifanib	10	uM	LJP6	72	hr	1097	1687	3673	0.4595	0.2791

|<
<<
Previous
Page 108 of 166
Next
>>
>
2676 to 2700 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)